Existing and Future Drugs for the Treatment of the Dark Side of Addiction - PubMed

Review

Existing and Future Drugs for the Treatment of the Dark Side of Addiction

George F Koob et al. Annu Rev Pharmacol Toxicol. 2016.

Abstract

The identification of a heuristic framework for the stages of the addiction cycle that are linked to neurocircuitry changes in pathophysiology includes the binge/intoxication stage, the withdrawal/negative affect stage, and the preoccupation/anticipation (craving) stage, which represent neuroadaptations in three neurocircuits (basal ganglia, extended amygdala, and frontal cortex, respectively). The identification of excellent and validated animal models, the development of human laboratory models, and an enormous surge in our understanding of neurocircuitry and neuropharmacological mechanisms have provided a revisionist view of addiction that emphasizes the loss of brain reward function and gain of stress function that drive negative reinforcement (the dark side of addiction) as a key to compulsive drug seeking. Reversing the dark side of addiction not only explains much of the existing successful pharmacotherapies for addiction but also points to vast new opportunities for future medications to alleviate this major source of human suffering.

Keywords: alcoholism; drug addiction; medication development; neurobiology; relapse; stress; withdrawal.

Similar articles

• Development of pharmacotherapies for drug addiction: a Rosetta stone approach.

  Koob GF, Kenneth Lloyd G, Mason BJ. Koob GF, et al. Nat Rev Drug Discov. 2009 Jun;8(6):500-15. doi: 10.1038/nrd2828. Nat Rev Drug Discov. 2009. PMID: 19483710 Free PMC article. Review.

• Emerging pharmacotherapies for alcohol use disorder.

  Mason BJ. Mason BJ. Neuropharmacology. 2017 Aug 1;122:244-253. doi: 10.1016/j.neuropharm.2017.04.032. Epub 2017 Apr 25. Neuropharmacology. 2017. PMID: 28454983 Free PMC article. Review.

• Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

  Koob GF. Koob GF. Pharmacol Rev. 2021 Jan;73(1):163-201. doi: 10.1124/pharmrev.120.000083. Pharmacol Rev. 2021. PMID: 33318153 Free PMC article. Review.

• Neurobiology of addiction: a neurocircuitry analysis.

  Koob GF, Volkow ND. Koob GF, et al. Lancet Psychiatry. 2016 Aug;3(8):760-773. doi: 10.1016/S2215-0366(16)00104-8. Lancet Psychiatry. 2016. PMID: 27475769 Free PMC article. Review.

• Addiction as a stress surfeit disorder.

  Koob GF, Buck CL, Cohen A, Edwards S, Park PE, Schlosburg JE, Schmeichel B, Vendruscolo LF, Wade CL, Whitfield TW Jr, George O. Koob GF, et al. Neuropharmacology. 2014 Jan;76 Pt B(0 0):370-82. doi: 10.1016/j.neuropharm.2013.05.024. Epub 2013 Jun 6. Neuropharmacology. 2014. PMID: 23747571 Free PMC article. Review.

Cited by

• Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugs.

  Lydon-Staley DM, Cleveland HH, Huhn AS, Cleveland MJ, Harris J, Stankoski D, Deneke E, Meyer RE, Bunce SC. Lydon-Staley DM, et al. Addict Behav. 2017 Feb;65:275-282. doi: 10.1016/j.addbeh.2016.08.026. Epub 2016 Aug 15. Addict Behav. 2017. PMID: 27544697 Free PMC article.

• Prevention of relapse to methamphetamine self-administration by environmental enrichment: involvement of glucocorticoid receptors.

  Nicolas C, Hofford RS, Dugast E, Lardeux V, Belujon P, Solinas M, Bardo MT, Thiriet N. Nicolas C, et al. Psychopharmacology (Berl). 2022 Apr;239(4):1009-1018. doi: 10.1007/s00213-021-05770-6. Epub 2021 Mar 25. Psychopharmacology (Berl). 2022. PMID: 33768375

• CR-19-0950: Event-related responses to alcohol-related stimuli in Mexican-American young adults: Relation to age, gender, comorbidity and "dark side" symptoms.

  Ehlers CL, Phillips E, Kim C, Wills DN, Karriker-Jaffe KJ, Gilder DA. Ehlers CL, et al. Drug Alcohol Depend. 2019 Sep 1;202:76-86. doi: 10.1016/j.drugalcdep.2019.06.001. Epub 2019 Jul 6. Drug Alcohol Depend. 2019. PMID: 31323376 Free PMC article.

• Multi-modal neuroimaging reveals differences in alcohol-cue reactivity but not neurometabolite concentrations in adolescents who drink alcohol.

  Kirkland AE, Green R, Browning BD, Aghamoosa S, Meyerhoff DJ, Ferguson PL, Tomko RL, Gray KM, Squeglia LM. Kirkland AE, et al. Drug Alcohol Depend. 2024 Apr 1;257:111254. doi: 10.1016/j.drugalcdep.2024.111254. Epub 2024 Mar 2. Drug Alcohol Depend. 2024. PMID: 38457964

• The central extended amygdala in fear and anxiety: Closing the gap between mechanistic and neuroimaging research.

  Fox AS, Shackman AJ. Fox AS, et al. Neurosci Lett. 2019 Feb 6;693:58-67. doi: 10.1016/j.neulet.2017.11.056. Epub 2017 Nov 30. Neurosci Lett. 2019. PMID: 29195911 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ingenta plc

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information